Zidovudine

NDC 31722-509 · Camber Pharmaceuticals, Inc.

Generic nameZidovudine

Dosage formTABLET

RouteORAL

Active ingredient(s)ZIDOVUDINE

Strength300 mg/1

Pharmacologic classHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]

Marketing categoryANDA

Packages

31722-509-60 — 12 BOTTLE in 1 CASE (31722-509-60) / 60 TABLET in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

31722-506 — LAMIVUDINE and ZIDOVUDINE, 31722-739 — Lamivudine and Zidovudine, 33342-003 — Lamivudine and Zidovudine, 43063-900 — LAMIVUDINE and ZIDOVUDINE, 49702-202 — lamivudine and zidovudine, 49702-211 — zidovudine, 49702-212 — zidovudine, 49702-213 — zidovudine, 65862-024 — Zidovudine, 65862-036 — Lamivudine and Zidovudine, 65862-048 — Zidovudine, 65862-107 — Zidovudine, 67046-1613 — Zidovudine, 68180-286 — ABACAVIR , LAMIVUDINE AND ZIDOVUDINE, 71335-0639 — LAMIVUDINE and ZIDOVUDINE, 71335-1916 — Lamivudine and Zidovudine, 72865-144 — lamivudine and zidovudine, 76282-115 — Lamivudine and Zidovudine

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.